Healthcare Cost

AJMC® in the Press, September 24, 2021

September 24th 2021, 2:47pm


Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

What We’re Reading: US Set to Increase Vaccine Donation; Home Births Increase; Aduhelm Sales Slower Than Expected

September 22nd 2021, 3:31pm


President Joe Biden reportedly will increase global COVID-19 vaccine donations; the pandemic may have led to an increase in home births; use of Biogen’s Adulhelm, an Alzheimer disease drug, does not hit initial projections.

Spotlighting Pandemic-Related Challenges, Data-Driven Solutions for Payers

September 21st 2021, 3:30pm


On this episode of Managed Care Cast, we address how delays in routine care and other aspects of the pandemic are affecting payer organizations today, and how technology innovations like natural language processing can work to empower key initiatives in population health and beyond.

PCOS Estimated to Cost $8 Billion in Immediate, Long-term Health Issues

September 21st 2021, 1:00pm


An updated report shows that the long-term cost of treating the health effects of polycystic ovary syndrome (PCOS)—$4.3 billion—is even higher than $3.7 billion it takes to diagnose and treat immediate issues that present for women who are of reproductive age.

Care Utilization, Costs Significantly Differ Between First-Line Metastatic Melanoma Treatments

September 17th 2021, 12:20pm


A study of patients given first-line metastatic melanoma treatment showed that utilization rates were highest in patients using ipilimumab-containing therapies.

High OOP Costs for Treatment of Psoriatic Disease Found in Medicare Beneficiaries

September 15th 2021, 7:15pm


Medicare beneficiaries with psoriasis and psoriatic arthritis were found to pay high annual out-of-pocket (OOP) costs for treatment, which researchers attributed to rising drug prices and reliance on co-insurance for patient cost-sharing.

Dr Joseph Alvarnas on the Speakers, Sessions to Watch at PCOC 2021

September 15th 2021, 6:00pm


Looking forward to the 10th anniversary of the Patient-Centered Oncology Care® (PCOC) conference, taking place in a hybrid format September 23-24, 2021, Joseph Alvarnas, MD, of City of Hope, editor-in-chief of Evidence-Based Oncology™, and co-chair of the meeting, discusses the takeaways that attendees can expect to hear about in the areas of patient care, payment and quality, and multidisciplinary collaboration among specialists.

What We’re Reading: Billions Spent on Preventable COVID-19 Hospitalizations; US Seeks to Bar Texas Abortion Law; States Limit Public Health Officials

September 15th 2021, 3:59pm


COVID-19 hospitalizations among the unvaccinated cost billions between June and August; the Department of Justice called for a temporary block on the Texas abortion law; legislators limited the power of public health officials in at least 26 states, a report shows.

Improving Outcomes-Based Managed Entry Agreements for SMA Therapy

September 12th 2021, 12:00am


Innovative therapies for rare diseases such as spinal muscular atrophy (SMA), when paid for by public budgets in the European Union and elsewhere, are often managed by agreements between payers and drug companies, but details can be hard to discern.

More Focus Needed on Prescribing Disparities for INSTI HIV Treatment

September 10th 2021, 5:30pm


Data from 2 patient cohorts show that by increasing awareness of such influences as clinic location and patient age and transgender status, gaps in prescription decisions for integrase strand transfer inhibitors (INSTIs) can be lessened.